Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 31 (November 1), 2006: pp. 5079-5090
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.1748

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Table A5 Supplements
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, D. N.
Right arrow Articles by Meyerson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, D. N.
Right arrow Articles by Meyerson, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

REVIEW ARTICLE

Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts

D. Neil Hayes, Stefano Monti, Giovanni Parmigiani, C. Blake Gilks, Katsuhiko Naoki, Arindam Bhattacharjee, Mark A. Socinski, Charles Perou, Matthew Meyerson

From the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge; Departments of Medical Oncology and Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston; Agilent Technologies, Andover, MA; Department of Biostatistics, The Johns Hopkins University School of Medicine, Baltimore, MD; Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada; and Yokohama Municipal Hospital, Yokohama, Japan

Address reprint requests to D. Neil Hayes, MD, MPH, Assistant Professor of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, CB #7295, Chapel Hill, NC 27599-7295; e-mail: hayes{at}med.unc.edu

Purpose Published reports suggest that DNA microarrays identify clinically meaningful subtypes of lung adenocarcinomas not recognizable by other routine tests. This report is an investigation of the reproducibility of the reported tumor subtypes.

Methods Three independent cohorts of patients with lung cancer were evaluated using a variety of DNA microarray assays. Using the integrative correlations method, a subset of genes was selected, the reliability of which was acceptable across the different DNA microarray platforms. Tumor subtypes were selected using consensus clustering and genes distinguishing subtypes were identified using the weighted difference statistic. Gene lists were compared across cohorts using centroids and gene set enrichment analysis.

Results Cohorts of 31, 72, and 128 adenocarcinomas were generated for a total of 231 microarrays, each with 2,553 reliable genes. Three adenocarcinoma subtypes were identified in each cohort. These were named bronchioid, squamoid, and magnoid according to their respective correlations with gene expression patterns from histologically defined bronchioalveolar carcinoma, squamous cell carcinoma, and large-cell carcinoma. Tumor subtypes were distinguishable by many hundreds of genes, and lists generated in one cohort were predictive of tumor subtypes in the two other cohorts. Tumor subtypes correlated with clinically relevant covariates, including stage-specific survival and metastatic pattern. Most notably, bronchioid tumors were correlated with improved survival in early-stage disease, whereas squamoid tumors were associated with better survival in advanced disease.

Conclusion DNA microarray analysis of lung adenocarcinomas identified reproducible tumor subtypes which differ significantly in clinically important behaviors such as stage-specific survival.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
S. Ocak, M. L. Sos, R. K. Thomas, and P. P. Massion
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Eur. Respir. J., August 1, 2009; 34(2): 489 - 506.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
N. A. Pennell and T. J. Lynch Jr.
Combined Inhibition of the VEGFR and EGFR Signaling Pathways in the Treatment of NSCLC
Oncologist, April 1, 2009; 14(4): 399 - 411.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Z.-H. Zhu, B.-Y. Sun, Y. Ma, J.-Y. Shao, H. Long, X. Zhang, J.-H. Fu, L.-J. Zhang, X.-D. Su, Q.-L. Wu, et al.
Three Immunomarker Support Vector Machines-Based Prognostic Classifiers for Stage IB Non-Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2009; 27(7): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. J. Giordano, R. Kuick, T. Else, P. G. Gauger, M. Vinco, J. Bauersfeld, D. Sanders, D. G. Thomas, G. Doherty, and G. Hammer
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
Clin. Cancer Res., January 15, 2009; 15(2): 668 - 676.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. L. Guo, Y.-W. Wan, K. Tosun, H. Lin, Z. Msiska, D. C. Flynn, S. C. Remick, V. Vallyathan, A. Dowlati, X. Shi, et al.
Confirmation of Gene Expression-Based Prediction of Survival in Non-Small Cell Lung Cancer
Clin. Cancer Res., December 15, 2008; 14(24): 8213 - 8220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. P. Massion, Y. Zou, H. Chen, A. Jiang, P. Coulson, C. I. Amos, X. Wu, I. Wistuba, Q. Wei, Y. Shyr, et al.
Smoking-related Genomic Signatures in Non-Small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1164 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Owzar, W. T. Barry, S.-H. Jung, I. Sohn, and S. L. George
Statistical Challenges in Preprocessing in Microarray Experiments in Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 5959 - 5966.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Bhojwani, H. Kang, R. X. Menezes, W. Yang, H. Sather, N. P. Moskowitz, D.-J. Min, J. W. Potter, R. Harvey, S. P. Hunger, et al.
Gene Expression Signatures Predictive of Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
J. Clin. Oncol., September 20, 2008; 26(27): 4376 - 4384.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Horlings, R. K. van Laar, J.-M. Kerst, H. H. Helgason, J. Wesseling, J. J.M. van der Hoeven, M. O. Warmoes, A. Floore, A. Witteveen, J. Lahti-Domenici, et al.
Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown Primary
J. Clin. Oncol., September 20, 2008; 26(27): 4435 - 4441.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. P. Koivunen, C. Mermel, K. Zejnullahu, C. Murphy, E. Lifshits, A. J. Holmes, H. G. Choi, J. Kim, D. Chiang, R. Thomas, et al.
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Clin. Cancer Res., July 1, 2008; 14(13): 4275 - 4283.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Shah, N. E. Sharpless, and D. N. Hayes
LKB1 and Lung Cancer: More Than the Usual Suspects
Cancer Res., May 15, 2008; 68(10): 3562 - 3565.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Yatabe, T. Takahashi, and T. Mitsudomi
Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer
Cancer Res., April 1, 2008; 68(7): 2106 - 2111.
[Abstract] [Full Text] [PDF]


Home page
BiostatisticsHome page
E. Garrett-Mayer, G. Parmigiani, X. Zhong, L. Cope, and E. Gabrielson
Cross-study validation and combined analysis of gene expression microarray data
Biostat., April 1, 2008; 9(2): 333 - 354.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Stearman, L. Dwyer-Nield, M. C. Grady, A. M. Malkinson, and M. W. Geraci
A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment
Cancer Res., January 1, 2008; 68(1): 34 - 43.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
D. Angeloni
Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease
Brief Funct Genomic Proteomic, May 24, 2007; (2007) elm007v1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Tamayo, D. Scanfeld, B. L. Ebert, M. A. Gillette, C. W. M. Roberts, and J. P. Mesirov
Metagene projection for cross-platform, cross-species characterization of global transcriptional states
PNAS, April 3, 2007; 104(14): 5959 - 5964.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online